Insight Molecular Diagnostics Inc (0KCC.L)

Name: Insight Molecular Diagnostics Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Pharmaceuticals

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$1.1M

Net Income

-$23.0M

Operating Margin

-253.6%

Free Cash Flow

-$22.2M

Debt / Assets

222.2%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Insight Molecular Diagnostics Inc (0KCC.L).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	1,139,000	260,000	518,000	2,138,000
Cost of Revenue	655,000	121,000	168,000	813,000
Gross Profit	484,000	139,000	350,000	1,325,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	4,617,000	3,931,000	4,107,000	4,321,000
Operating Expenses	23,264,000	11,187,000	10,192,000	8,124,000
Operating Income	-2,889,000	-11,048,000	-9,842,000	-6,799,000
Interest Expense	26,000	29,000	25,000	29,000
Income Before Tax	-22,955,000	-10,854,000	-9,742,000	-6,671,000
Income Tax Expense	0	0	0	0
Net Income	-22,955,000	-10,854,000	-9,742,000	-6,671,000
Per Share
EPS	-0.75	-0.34	-0.30	-0.26
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Insight Molecular Diagnostics Inc (0KCC.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	4,055,000	1,881,000	1,503,000	958,000
Cost of Revenue	1,757,000	1,141,000	1,090,000	6,196,000
Gross Profit	2,298,000	740,000	413,000	-5,238,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	16,976,000	13,785,000	13,536,000	16,628,000
Operating Expenses	51,665,000	61,781,000	25,637,000	23,593,000
Operating Income	-30,578,000	-61,041,000	-25,136,000	-28,831,000
Interest Expense	109,000	84,000	52,000	77,000
Income Before Tax	-50,222,000	-60,663,000	-24,855,000	-18,612,000
Income Tax Expense	0	0	0	520,000
Net Income	-50,222,000	-60,663,000	-27,781,000	-72,902,000
Per Share
EPS	-1.65	-4.66	-3.75	-13.16
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Insight Molecular Diagnostics Inc (0KCC.L).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	11,583,000	8,636,000	9,432,000	19,993,000
Short Term Investments	0	0	0	433,000
Net Receivables	1,128,000	1,613,000	484,000	2,012,000
Inventory	446,000	410,000	0	0
Total Current Assets	15,306,000	11,759,000	10,698,000	25,536,000
Property Plant Equipment	2,815,000	2,757,000	5,436,000	10,851,000
Goodwill and Intangibles	0	14,607,000	56,595,000	61,633,000
Total Assets	25,756,000	35,081,000	74,892,000	100,091,000
Liabilities
Account Payables	2,544,000	2,279,000	953,000	1,253,000
Short Term Debt	1,807,000	1,295,000	665,000	815,000
Total Current Liabilities	12,075,000	7,275,000	7,194,000	12,106,000
Long Term Debt	3,380,000	2,369,000	2,204,000	0
Total Liabilities	57,220,000	47,355,000	49,298,000	60,497,000
Shareholders Equity
Retained Earnings	-400,761,000	-350,539,000	-289,876,000	-260,676,000
Total Shareholders Equity	-31,464,000	-12,274,000	25,594,000	39,594,000

Balance sheet annual history for Insight Molecular Diagnostics Inc (0KCC.L).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	11,583,000	8,636,000	9,432,000	19,993,000
Short Term Investments	0	0	0	433,000
Net Receivables	1,128,000	1,613,000	484,000	2,012,000
Inventory	446,000	410,000	0	0
Total Current Assets	15,306,000	11,759,000	10,698,000	25,536,000
Property Plant Equipment	2,815,000	2,757,000	5,436,000	10,851,000
Goodwill and Intangibles	0	14,607,000	56,595,000	61,633,000
Total Assets	25,756,000	35,081,000	74,892,000	100,091,000
Liabilities
Account Payables	2,544,000	2,279,000	953,000	1,253,000
Short Term Debt	1,807,000	1,295,000	665,000	815,000
Total Current Liabilities	12,075,000	7,275,000	7,194,000	12,106,000
Long Term Debt	3,380,000	2,369,000	2,204,000	0
Total Liabilities	57,220,000	47,355,000	49,298,000	60,497,000
Shareholders Equity
Retained Earnings	-400,761,000	-350,539,000	-289,876,000	-260,676,000
Total Shareholders Equity	-31,464,000	-12,274,000	25,594,000	39,594,000

Cash flow quarterly history for Insight Molecular Diagnostics Inc (0KCC.L).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-50,222,000	-60,663,000	-27,781,000	-18,612,000
Depreciation & Amortization	2,197,000	1,564,000	1,680,000	5,220,000
Stock Based Compensation	2,219,000	1,913,000	6,573,000	6,479,000
Change in Working Capital	2,727,000	-1,321,000	-3,971,000	-1,942,000
Operating Cash Flow	-22,184,000	-20,713,000	-23,325,000	-45,568,000
Investing Activities
Capital Expenditure	-3,185,000	-516,000	-281,000	-4,340,000
Investments	-3,185,000	-516,000	-281,000	-4,340,000
Investing Cash Flow	-3,185,000	-512,000	-932,000	-4,340,000
Financing Activities
Debt Repayment	-510,000	-201,000	-117,000	-1,429,000
Common Stock Issued/Repurchased	28,656,000	27,814,000	12,730,000	37,236,000
Dividends Paid	0	0	0	0
Financing Cash Flow	28,072,000	20,429,000	12,186,000	35,806,000
Summary
Free Cash Flow	-22,184,000	-21,229,000	-23,606,000	-49,908,000
Net Change in Cash	3,676,000	-796,000	-12,071,000	-12,955,000

Cash flow annual history for Insight Molecular Diagnostics Inc (0KCC.L).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-50,222,000	-60,663,000	-27,781,000	-18,612,000
Depreciation & Amortization	2,197,000	1,564,000	1,680,000	5,220,000
Stock Based Compensation	2,219,000	1,913,000	6,573,000	6,479,000
Change in Working Capital	2,727,000	-1,321,000	-3,971,000	-1,942,000
Operating Cash Flow	-22,184,000	-20,713,000	-23,325,000	-45,568,000
Investing Activities
Capital Expenditure	-3,185,000	-516,000	-281,000	-4,340,000
Investments	-3,185,000	-516,000	-281,000	-4,340,000
Investing Cash Flow	-3,185,000	-512,000	-932,000	-4,340,000
Financing Activities
Debt Repayment	-510,000	-201,000	-117,000	-1,429,000
Common Stock Issued/Repurchased	28,656,000	27,814,000	12,730,000	37,236,000
Dividends Paid	0	0	0	0
Financing Cash Flow	28,072,000	20,429,000	12,186,000	35,806,000
Summary
Free Cash Flow	-22,184,000	-21,229,000	-23,606,000	-49,908,000
Net Change in Cash	3,676,000	-796,000	-12,071,000	-12,955,000